» Articles » PMID: 35520220

Spermine Modified Polymeric Micelles with PH-sensitive Drug Release for Targeted and Enhanced Antitumor Therapy

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 6
PMID 35520220
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor targeting delivery of chemotherapeutic drugs by nanocarriers has been demonstrated to be a promising strategy for cancer therapy with improved therapeutic efficacy. In this work, we reported a novel type of active targeting micelle with pH-responsive drug release by using biodegradable poly(lactide)-poly(2-ethyl-2-oxazoline) di-block copolymers functionalized with spermine (SPM). SPM has been considered as a tumor binding ligand through its specific interaction with the polyamine transport system (PTS), a transmembrane protein overexpressed on various types of cancer cell, while its application in nano-drug delivery systems has rarely been explored. The micelles with spherical shape (∼110 nm) could load hydrophobic paclitaxel (PTX) with high capacity, and release the payload much faster at acidic pH (4.5-6.5) than at pH 7.4. This pH-responsive property assisted the rapid escape of drug from the endo/lysosome after internalization as demonstrated by confocal laser scanning microscopy images using coumarin-6 (Cou-6) as a fluorescent probe. With surface SPM modification, the micelles displayed much higher cellular uptake than SPM lacking micelles in various types of cancer cells, demonstrating tumor targeting ability. The uptake mechanism of SPM modified micelles was explored by flow cytometry, which suggested an energy-consuming sag vesicle-mediated endocytosis pathway. As expected, the micelles displayed significantly enhanced anti-cancer activity. This work demonstrates that SPM modified pH-sensitive micelles may be potential drug delivery vehicles for targeting and effective cancer therapy.

Citing Articles

A shielded cascade of targeted nanocarriers spanning multiple microenvironmental barriers for inflammatory disease therapy.

Liu F, Wang X, Ren M, He P, Li Y, Cui J J Nanobiotechnology. 2024; 22(1):789.

PMID: 39710698 PMC: 11665124. DOI: 10.1186/s12951-024-03075-2.


Targeting Peptides: The New Generation of Targeted Drug Delivery Systems.

Todaro B, Ottalagana E, Luin S, Santi M Pharmaceutics. 2023; 15(6).

PMID: 37376097 PMC: 10300729. DOI: 10.3390/pharmaceutics15061648.


Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis.

Xiao X, Chen M, Zhang Y, Li L, Peng Y, Li J J Nanobiotechnology. 2022; 20(1):410.

PMID: 36109814 PMC: 9479271. DOI: 10.1186/s12951-022-01617-0.


Naturally Equipped Urinary Exosomes Coated Poly (2-ethyl-2-oxazoline)-Poly (D, L-lactide) Nanocarriers for the Pre-Clinical Translation of Breast Cancer.

Ni J, Mi Y, Wang B, Zhu Y, Ding Y, Ding Y Bioengineering (Basel). 2022; 9(8).

PMID: 36004889 PMC: 9404723. DOI: 10.3390/bioengineering9080363.

References
1.
Liggins R, Burt H . Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev. 2002; 54(2):191-202. DOI: 10.1016/s0169-409x(02)00016-9. View

2.
Arranja A, Pathak V, Lammers T, Shi Y . Tumor-targeted nanomedicines for cancer theranostics. Pharmacol Res. 2016; 115:87-95. PMC: 5412956. DOI: 10.1016/j.phrs.2016.11.014. View

3.
Kesharwani P, Iyer A . Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. Drug Discov Today. 2015; 20(5):536-47. PMC: 4433832. DOI: 10.1016/j.drudis.2014.12.012. View

4.
Mizrahy S, Rebe Raz S, Hasgaard M, Liu H, Soffer-Tsur N, Cohen K . Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. J Control Release. 2011; 156(2):231-8. DOI: 10.1016/j.jconrel.2011.06.031. View

5.
Xie Y, Murray-Stewart T, Wang Y, Yu F, Li J, Marton L . Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy. J Control Release. 2016; 246:110-119. PMC: 5258827. DOI: 10.1016/j.jconrel.2016.12.017. View